• AXIS Clinicals successfully completes 25th US FDA audit (November 2018)
  • AXIS Clinicals successfully completes 4th MHRA audit (June 2018)
  • AXIS Clinicals successfully completes 2nd WHO audit (December 2017)
  • AXIS Clinicals successfully completes AEMPS Spain (December 2018)
  • AXIS Clinicals successfully completes INFARMED Portugal (June 2018)
  • AXIS Clinicals successfully completes NPRA Malaysia (June 2018)
  • AXIS Clinicals successfully completes GCC audit (February 2016)
  • AXIS Clinicals successfully completes MCC South Africa audit (March 2017)
  • BA-BE studies conducted at AXIS Clinicals are accepted by Chile – ISP

Our Leadership

doctor

B. Phani Bhushana Reddy
Executive Director
Mr. Phani brings more than 18 years experience in the conduct of Bio-analysis for pharmaceutical and Bio-pharmaceutics drugs. He has extensive expertise in Hormonal drugs method development & validations and metabolic profiling. Phani has published various papers on Bio-analysis in chromatography journals.

doctor

Dr. A. Jayachandra Reddy
Executive Director
Dr. Jaya Chandra Reddy, has more than 15 years of experience. He has completed Post Graduation in Medicine and also received FRCS from University of Edinburgh. He is responsible for setting up BA|BE centers in various countries, meeting international regulatory requirements (USFDA, UK-MHRA, WHO, ANVISA-Brazil, Turkey-MOH, DCGI and other regulatory agencies like TPP-Canada, TGA-Australia, etc.) and handling all regulatory and client audits successfully

doctor

Dr. Subhra Lahiri
AVP – Clinical Research
Dr. Subhra has over 24 years of extensive experience in Clinical Research, Clinical Data Management, Pharmaceuticals and Biologics. Before joining AXIS Clinicals, he worked in various domains like Clinical Research, Clinical Data Management, Regulatory Affairs and Drug Development activities for Bharat Biotech, Biological E., Asian Clinical Trials and Avesthagen. He has experience in conducting several clinical studies including early exploratory trials, Patient population Bioequivalence studies and clinical trials in various therapeutic areas. He has obtained his PhD degree in Human Physiology from University of Calcutta.

doctor

Abhijit Chaudhari
Director – Business Dev. (India / ROW)
Mr. Abhijit brings more than 16 years of experience in Pharmaceutical and Clinical Research fraternity in various domains like Business Development, Brand Management, Product Management and Project Management. Prior to AXIS Clinicals, Abhijit worked with Cadila Pharmaceuticals, GVK BIO, Actimus Biosciences; where he demonstrated success in setting and executing business strategy, leading complex cross-functional projects and developing strong customer relationships. He hold Bachelor’s degree in Pharmacy (B. Pharmacy) and Masters in Business Administration (MBA) from University of Pune.

doctor

Dr.Nirav R. Shah
General Manager & Head Operations - Ahmedabad
Dr. Nirav brings more than 18 years of experience in the field of Clinical Research including BA/BE Studies and Phase trials. He has successfully faced DCGI, USFDA, UK-MHRA, WHO and many more regulatory audits in his tenure. Before joining AXIS Clinicals, he worked with Accutest, Synchron and Lambda Therapeutics. He hold Bachelor`s degree in Medical (M.B.B.S.) and Masters in Clinical Research (MSc) from Gujarat University.

doctor

Dr. Rajani Kumar
General Manager, Bioanalytical
Dr. Rajani Kumar completed M. Pharmacy (in Pharmaceutical and food analysis) from Andhra University and later obtained Ph.D in Bioanalysis from Nagarjuna University. Has 18+ years of rich experience in CROs and pharmaceutical companies like SIPRA Laboratories and Ranbaxy Laboratories. Associating with AXIS clinicals Limited, Hyderabad from past 12 years and heading the bioanalytical department. Expertise in executing bioanalysis of biostudies from pilot to pivotal stage for different formulations like injectables, nasal sprays and topical preparations besides conventional dosage forms.

doctor

Dr Ravinder Sreedasyam
General Manager – Quality Assurances
Dr Ravinder Sreedasyam holds a PhD in Analytical Chemistry with over 20 years of experience in quality and regulatory compliance functions. Prior to joining AXIS, he had been associated with reputed pharma companies like Aurobindo Pharma and Dr. Reddy’s Laboratories.

doctor

Dr. Nagaraj Kumar. N
General Manager - Pharmacokinetics and Biostatistics
Dr Nagaraj Kumar. N brings more than 19 years of combined experience in Pharmaceutical R & D and Contract Research, supporting the generic drug development, for multiple dosage forms with diverse therapeutic benefit. He has hands on operational experience in Clinical, Bio analytical, Pharmacokinetics and Bio pharmaceutics. Before Joining Axis Clinicals Ltd., he was associated with Sandoz, Perrigo, Aurobindo, Welquest and Vimta. He perused Master’s Degree and Doctoral Research Program in Pharmacy from KLE University, Belgaum.

Fact sheet

  • 2,600+ clinical studies completed since inception
  • 350+ bioanalytical methods developed
  • 50+ successful Regulatory audits
  • Global footprint of operations with sites in India, U.S & Mexico.
  • Two clinical facilities (Hyderabad & Ahmedabad) in India
  • 100+ National and International Pharma/Biotech Sponsor companies working with AXIS
  • US FDA : 500+ approvals, EMEA : 100+ approvals, Canada : 50+ approvals, Australia : 50+ approvals
  • 500+ experienced employees working globally
  • Huge database of patient population in various therapeutic areas viz. Cardiology, Opthalmology, Schizophrenia, Diabetology, Oncology. Orthopedics etc..

Copyright Axis Clinicals - All Rights Reserved